ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

IONS Ionis Pharmaceuticals Inc

43,35
-1,31 (-2,93%)
Nach Börsenschluss
Zuletzt aktualisiert: 21:00:10
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-1,31 -2,93% 43,35 21:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
44,95 43,32 44,95 43,35 44,66
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
28.3.202412:05PRNUSIonis to hold olezarsen Phase 3 data webcast
25.3.202413:18PRNUSPositive olezarsen Phase 3 data in familial chylomicronemia..
13.3.202412:00PRNUSIonis announces positive results from Phase 2 study of..
06.3.202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
05.3.202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202415:10EDGAR2Form 8-K - Current report
29.2.202415:05PRNUSIonis announces new chief global product strategy officer to..
28.2.202413:05PRNUSIonis to present at upcoming investor conferences
21.2.202417:17EDGAR2Form 8-K - Current report
21.2.202413:00PRNUSIonis reports fourth quarter and full year 2023 financial..
20.2.202416:39EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17.2.202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:34EDGAR2Form 144 - Report of proposed sale of securities
15.2.202413:00PRNUSOlezarsen receives Orphan Drug designation from U.S. FDA for..
14.2.202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13.2.202412:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202413:00PRNUSEplontersen granted U.S. FDA Fast Track designation for..
07.2.202413:05PRNUSIonis to hold fourth quarter and full year 2023 financial..
03.2.202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202423:34EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:31EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:30EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:28EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:25EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:23EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:21EDGAR2Form 144 - Report of proposed sale of securities
02.2.202423:19EDGAR2Form 144 - Report of proposed sale of securities
01.2.202403:30EDGAR2Form 144 - Report of proposed sale of securities
29.1.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202420:37EDGAR2Form 144 - Report of proposed sale of securities
26.1.202420:09EDGAR2Form 144 - Report of proposed sale of securities
22.1.202413:10EDGAR2Form 8-K - Current report
22.1.202413:00PRNUSIonis announces positive topline results from Phase 3..
19.1.202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock